Viewing Study NCT01974518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-02-08 @ 11:36 AM
Study NCT ID: NCT01974518
Status: UNKNOWN
Last Update Posted: 2014-10-30
First Post: 2013-10-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Sponsor: Uprety Shraddha
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pemphigus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pemphigus View
None Rituximab View
None Rituximab and IV cyclophosphamide combination View
None B cell re-population characteristics following Rituximab View